Blockade of CD14 aggravates experimental shigellosis

Abstract

Shigella infections lead to severe inflammation associated with destruction of colonic mucosa. We assessed the effect of in vivo blockade of CD14 on the outcome of experimental Shigella infection in rabbits. A total of 17 rabbits were divided into two groups: 8 received a single i.v. dose of anti-rabbit CD14 monoclonal antibody prior to infection with an invasive Shigella flexneri strain; the remainder served as controls. The anti-CD14-treated rabbits exhibited more severe tissue destruction and a 50-fold increase in bacterial invasion of the intestinal mucosa when compared to controls. Similar numbers of polymorphonuclear leukocytes were recruited to the intestinal mucosa in both groups despite the massive bacterial invasion seen in the CD14-blocked group. No statistically significant differences were seen in levels of IL-1β nor in the ratio of IL-1RA/IL-1β for either group. In contrast, higher quantities of TNF-α were observed in the CD14-blocked group. To conclude, anti-CD14 treatment had a detrimental effect on the capacity of Shigella-infected animals to clear the infection.

References

Who. Manual for the Treatment of Diarrhoea: for use by physicians and other senior health workers. Geneva: World Health Organization, 1990.

Parsot C. Shigella flexneri: genetics of entry and intercellular dissemination in epithelial cells. Curr Top Microbiol Immunol 1994; 192: 217—241.

Grau GE , Maennel DN TNF inhibition and sepsis — sounding a cautionary note. Nat Med 1997; 3: 1193—1195.

Giroir B. , Quint PA , Barton P. et al. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 1997; 350: 1439—1443.

Sansonetti PJ , Arondel J. , Cavaillon J-M. , Huerre M. Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest 1995; 96: 884—892.

Wright SD , Ramos RA , Tobias PS , Ulevitch RJ , Mathison JC CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431—1433.

Pugin J. , Heumann ID , Tomasz A. et al. CD14 is a pattern recognition receptor. Immunity 1994; 1: 509—516.

Leturcq DJ , Moriarty AM , Talbott G. , Winn RK , Martin TR , Ulevitch RJ Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 1996; 98: 1533—1538.

Ferrero E. , Jiao D. , Tsuberi BZ et al. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90: 2380—2384.

10.

Haziot A. , Ferrero E. , Köntgen F. et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4: 407—414.

11.

Schimke J. , Mathison J. , Morgiewicz J. , Ulevitch RJ Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci USA 1998; 95: 13875—13880.

12.

Sansonetti PJ , Kopecko DJ , Formal SB Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun 1982; 35: 852—860.

13.

Clark BD , Bedrosian I. , Schindler R. et al. Detection of interleukin 1α and 1β in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol 1991; 71: 2412—2418.

14.

Matsukawa A. , Ohkawara S. , Maeda T. , Takagi K. , Yoshinaga M. Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin Exp Immunol 1993; 93: 206—211.

15.

Espevik T. , Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95: 99—105.

16.

Smith PD , Janoff EN , Mosteller-Barnum M. et al. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J Immunol Methods 1997; 202: 1—11.

17.

Mathan MM , Mathan VI Ultrastructural pathology of the rectal mucosa in Shigella dysentery. Am J Pathol 1986; 123: 25—38.

18.

Cross A. , Asher L. , Seguin M. et al. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. J Clin Invest 1995; 96: 676—686.

19.

Jack RS , Fan X. , Bernheiden M. et al. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature 1997; 389: 742—745.

20.

Zychlinsky A. , Thirumalai K. , Arondel J. , Cantey JR , Aliprantis AO , Sansonetti PJ In vivo apoptosis in Shigella flexneri infections . Infect Immun 1996; 64: 5357—5365.

21.

Lennard AC Interleukin-1 receptor antagonist. Crit Rev Immunol 1995; 15: 77—105.

22.

Abraham SN , Malaviya R. Mast cells in infection and immunity. Infect Immun 1997; 65: 3501—3508.